In today’s briefing:
- Shenzhen Mindray Bio-Medical Electronics (300760.CH) – Still a “Safe Play” Despite Growth Slowdown
Shenzhen Mindray Bio-Medical Electronics (300760.CH) – Still a “Safe Play” Despite Growth Slowdown
- In 2021/22Q1, Mindray’s 20%+ growth rate is not easy in this difficult/complicated environment, but the market hopes to see stronger data and a fresh logic of growth to restore confidence.
- After China’s “new infrastructure” projects finish, how to maintain its 20%+ growth could be a challenge in the long term if Mindray couldn’t make breakthrough in internationalization or innovation.
- However, Mindray is still a “safe play”. Its current PE/TTM is also more reasonable, but definitely not undervalued. It would be much better to long Mindray at a lower valuation.
Before it’s here, it’s on Smartkarma
